Discussion on predictors of response to infliximab in patients with Crohn's disease.
作者信息
Hommes Daan
出版信息
Gastroenterology. 2003 Jun;124(7):2002-3. doi: 10.1016/s0016-5085(03)00575-4.
Abstract
摘要
相似文献
1
Discussion on predictors of response to infliximab in patients with Crohn's disease.
Gastroenterology. 2003 Jun;124(7):2002-3. doi: 10.1016/s0016-5085(03)00575-4.
2
Systemic amyloidosis with Crohn's disease treated with infliximab.
Inflamm Bowel Dis. 2008 Mar;14(3):431-2. doi: 10.1002/ibd.20289.
3
Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for).
Inflamm Bowel Dis. 2000 May;6(2):137-9. doi: 10.1097/00054725-200005000-00011.
4
Infliximab treatment induces levels of the active azathioprine metabolite TGTP in Crohn's disease.
Inflamm Bowel Dis. 2013 Mar-Apr;19(4):E54-5. doi: 10.1002/ibd.22998.
5
Infliximab: how to use it in pediatric Crohn's disease.
J Pediatr Gastroenterol Nutr. 2004 Jul;39(1):12-4. doi: 10.1097/00005176-200407000-00004.
6
[Management and treatment of Crohn's disease. 2. Anti-cytokine therapy].
Nihon Naika Gakkai Zasshi. 2009 Jan 10;98(1):88-93. doi: 10.2169/naika.98.88.
7
[Recommendations for the use of infliximab (Remicade) in Crohn's disease. GETECCU 2001].
Gastroenterol Hepatol. 2002 Mar;25(3):162-9. doi: 10.1016/s0210-5705(02)79012-2.
8
Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
BioDrugs. 2002;16(2):111-48. doi: 10.2165/00063030-200216020-00005.
9
Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception.
Inflamm Bowel Dis. 2008 Mar;14(3):435-6. doi: 10.1002/ibd.20319.
10
[Adalimumab in infliximab refractory Crohn's disease -- the next generation of anti-TNF-alpha-therapy?].
Z Gastroenterol. 2005 Jul;43(7):689-90. doi: 10.1055/s-2005-858274.
Zotero 插件